41.34
前日終値:
$42.26
開ける:
$42.8
24時間の取引高:
1.11M
Relative Volume:
0.75
時価総額:
$7.64B
収益:
$29.52M
当期純損益:
$-567.06M
株価収益率:
-11.30
EPS:
-3.66
ネットキャッシュフロー:
$-551.11M
1週間 パフォーマンス:
+1.65%
1か月 パフォーマンス:
+2.94%
6か月 パフォーマンス:
-8.70%
1年 パフォーマンス:
+41.72%
Revolution Medicines Inc Stock (RVMD) Company Profile
名前
Revolution Medicines Inc
セクター
電話
415-766-3638
住所
700 SAGINAW DR, REDWOOD CITY, CA
RVMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RVMD
Revolution Medicines Inc
|
41.34 | 7.64B | 29.52M | -567.06M | -551.11M | -3.66 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-16 | 繰り返されました | Needham | Buy |
2024-07-12 | 開始されました | Barclays | Overweight |
2024-07-08 | 開始されました | Jefferies | Buy |
2024-04-12 | 繰り返されました | Needham | Buy |
2024-04-10 | アップグレード | Raymond James | Outperform → Strong Buy |
2024-03-11 | 開始されました | Piper Sandler | Overweight |
2024-01-05 | アップグレード | BofA Securities | Neutral → Buy |
2024-01-04 | 開始されました | Wedbush | Outperform |
2023-11-16 | 開始されました | Raymond James | Outperform |
2023-02-28 | アップグレード | JP Morgan | Neutral → Overweight |
2022-12-14 | 開始されました | Needham | Buy |
2022-10-21 | 開始されました | Oppenheimer | Outperform |
2022-05-20 | 開始されました | BofA Securities | Neutral |
2022-03-01 | アップグレード | Stifel | Hold → Buy |
2021-09-23 | 開始されました | Stifel | Hold |
2021-08-12 | ダウングレード | Goldman | Buy → Neutral |
2021-05-18 | 開始されました | Goldman | Buy |
2020-05-21 | 開始されました | H.C. Wainwright | Buy |
2020-03-09 | 開始されました | Cowen | Outperform |
2020-03-09 | 開始されました | Guggenheim | Buy |
2020-03-09 | 開始されました | JP Morgan | Neutral |
すべてを表示
Revolution Medicines Inc (RVMD) 最新ニュース
Revolution Medicines to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - The Manila Times
Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire
Revolution Medicines Q4 Earnings Coming: Will Their Cancer Drug Pipeline Show Progress? - StockTitan
(RVMD) Proactive Strategies - Stock Traders Daily
Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials - MSN
Wilmington Savings Fund Society FSB Sells 15,167 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
SG Americas Securities LLC Sells 28,515 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
Empowered Funds LLC Purchases New Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
Mirae Asset Global Investments Co. Ltd. Sells 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World
Wingate Wealth Advisors Inc. Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
WCM Investment Management LLC Takes $6.80 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect? - MSN
(RVMD) Trading Advice - Stock Traders Daily
Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance
12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey
Revolution Medicines Inc [RVMD] stock for 97,443 USD was sold by Cislini Jeff - Knox Daily
Stock Performance Spotlight: Revolution Medicines Inc (RVMD) Ends the Day at 43.57, Down by -1.54 - The Dwinnex
An analyst sees good growth prospects for Revolution Medicines Inc (RVMD) - SETE News
Revolution Medicines, Inc. (NASDAQ:RVMD) Stake Lifted by KBC Group NV - Defense World
China Universal Asset Management Co. Ltd. Buys 29,853 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
Revolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advances - MSN
Revolution Medicines’ SWOT analysis: stock shows promise amid cancer treatment advances - Investing.com Nigeria
Revolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advances By Investing.com - Investing.com South Africa
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates - MSN
Are Investors Undervaluing Revolution Medicines, Inc. (NASDAQ:RVMD) By 49%? - Simply Wall St
Is Revolution Medicines, Inc. (NASDAQ:RVMD) Trading At A 49% Discount? - Yahoo Finance
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Average Target Price from Brokerages - Defense World
Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference - The Manila Times
RAS Cancer Breakthrough? Revolution Medicines CEO Takes Center Stage at Major Biotech Event - StockTitan
Revolution Medicines: New Data Underscore A True Cancer Revolution (Upgrade) - Seeking Alpha
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.25 Average Target Price from Analysts - MarketBeat
Down -7.83% in 4 Weeks, Here's Why Revolution Medicines (RVMD) Looks Ripe for a Turnaround - MSN
Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials By Investing.com - Investing.com South Africa
Revolution Medicines general counsel Jeff Cislini sells $97,443 in stock - MSN
Revolution Medicines general counsel Jeff Cislini sells $97,443 in stock By Investing.com - Investing.com Australia
Sandy Cove Advisors LLC Acquires Shares of 42,008 Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat
Revolution Medicines Inc (RVMD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):